关注
Kopytsya Mykola
Kopytsya Mykola
Institut of Therapy, kharkov
在 amnu.gov.ua 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
2702019
Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment
GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ...
Diabetes Care 44 (5), 1219-1227, 2021
272021
PROGNOSTICATION OF CLINICAL OUTCOMES AFTER STEMI: THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A.
O Petyunina, M Kopytsya, I Kuznetsov, I Vyshnevska
Georgian medical news, 79-86, 2018
72018
Removal of the tumor thrombus from the right atrium without extracorporeal circulation: Emphasis on the displacement of the tumor apex
DV Shchukin, VN Lesovoy, GG Khareba, AI Harahatyi, AV Maltsev, ...
Advances in Urology 2020 (1), 6063018, 2020
62020
Lower circulating cell-free mitochondrial DNA is associated with heart failure in type 2 diabetes mellitus patients
TA Berezina, MP Kopytsya, OV Petyunina, AA Berezin, Z Obradovic, ...
Cardiogenetics 13 (1), 15-30, 2023
52023
The vascular endothelial growth factor-A gene polymorphism predicts clinical outcomes among acute ST-segment elevation myocardial infarction patient
IM Kutia, MP Kopytsya, YV Hilova, OV Petyunina, AE Berezin
52020
Biomarker-based prognostication of adverse cardiac remodeling after STEMI: the role of single nucleotide polymorphism T786C in endothelial NO-synthase gene
OV Petyunina, MP Kopytsya, AE Berezin
Journal of Cardiology and Therapy 6 (1), 768-774, 2019
52019
Biomarker SST2 as an early predictor of acute renal injury in patients with ST-segment elevation acute myocardial infarction.
I Vyshnevska, M Kopytsya, Y Hilоva, E Protsenko, O Petyunina
Georgian Medical News, 53-58, 2020
42020
Short-term clinical outcomes in patients with acute myocardial infarction after successful percutaneous coronary revascularization: the role of promoter polymorphism of the …
OV Petyunina, MP Kopytsya, DP Babichev, AE Berezin
Biomedical Research and Therapy 6 (5), 3166-3179, 2019
42019
Promising Role of Vascular Endothelial Growth Factor-A in Risk Stratification after PCI
OV Petyunina, MP Kopytsya, IS Rudyk, GS Isayeva
Vascular Access Surgery-Tips and Tricks, 2019
42019
Macrophage inhibitory factor predicted late cardiac remodeling in acute myocardial infarction patients underwent successful percutaneous coronary intervention
OV Petyunina, MP Kopytsya, AE Berezin
La Prensa Medica Argentina 105 (5), 160-169, 2019
42019
Features of the cardiovascular system lesion in patients with COVID-19
M Kopytsya, I Rodionova, N Tytarenko, Y Hilyova, I Kutya, A Kobets
ScienceRise: Medical Science, 4-12, 2020
32020
Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction
OV Petyunina, MP Kopytsya, AE Berezin
Biomedical Research and Therapy 5 (12), 2863-2875, 2018
32018
GROWTH DIFFERENTIATION FACTOR 15 AS A PROGNOSTIC MARKER OF CHRONIC HEART FAILURE PROGRESSION IN LONG-TERM FOLLOW-UP AFTER ACUTE CORONARY SYNDROME.
M Kopytsya, I Vyshnevska, O Protsenko, H Barahmeh
Georgian Medical News, 61-66, 2017
32017
The role of biomarker macrophage migration inhibitory factor in cardiac remodeling prediction in patients with st-segment elevation myocardial infarction
IR Vyshnevska, T Storozhenko, MP Kopytsya, NV Bila, A Kis, M Kaaki
Wiad Lek 76, 911-9, 2023
22023
Macrophage migration inhibitory factor levels predict no-reflow in ST-segment elevation myocardial infarction
TY Storozhenko, IR Vishnevskaya, MP Kopytsya, AE Berezin
22021
The role of growth differentiation factor 15 as a predictor of 5-year survival of patients after acute coronary syndrome.
IR Vyshnevska, MP Kopytsya, IM Kutya, OS Protsenko
Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 48 (287 …, 2020
22020
Особенности поражения сердечно-сосудистой системы при COVID-19
НП Копица, ЮВ Родионова, НВ Титаренко, ЯВ Гилёва, ИН Кутя, ...
Science Rise: Medical Science 3 (36), 4-12, 2020
22020
The role of Val66Met single nucleotide polymorphism in brain-derived neurotropic factor gene in prediction of adverse outcomes after ST-segment elevation myocardial infarction
OV Petyunina, MP Kopytsya, AE Berezin, OV Skrynnyk
Heart and Mind 3 (1), 7-14, 2019
22019
Васкулоендотеліальний фактор росту А та поліморфізм G634C гена ВЕФР-A у хворих інфарктом міокарда в гострий та віддалений періоди
МП Копиця, ІМ Кутя, ЮВ Родіонова
World science 2 (8 (36)), 11-17, 2018
22018
系统目前无法执行此操作,请稍后再试。
文章 1–20